{
    "code": "52026842",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026842",
    "time": "2022-09-09 06:09:24",
    "許可證字號": "衛部藥輸字第026842號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/07\/04",
    "發證日期": "105\/07\/04",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202684201",
    "中文品名": "鉑美特膠囊1毫克",
    "英文品名": "POMALYST 1mg capsules",
    "適應症": "POMALYST與bortezomib及dexamethasone 合併使用適用於治療先前曾接受至少一種治療(包括lenalidomide)的多發性骨髓瘤成人病人。POMALYST是一種thalidomide類似物，與dexamethasone合併使用，核准用於多發性骨髓瘤病人，且先前接受過含 lenalidomide和bortezomib在內的至少兩種療法，且確認完成前次治療時或結束治療後六十天內發生疾病惡化(disease progression)。",
    "劑型": "130膠囊劑",
    "包裝": "8~1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "110\/07\/04",
    "主成分略述": "Pomalidomide",
    "限制項目": "02輸　入 1D須執行風險管理計畫 5F免除銜接性試驗",
    "申請商名稱": "620117G076  賽基有限公司",
    "申請商地址": "臺北市松山區健康路156號5樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCH0247000  CELGENE INTERNATIONAL SARL",
            "製造廠廠址": "ROUTE DE PERREUX 1 2017 BOUDRY SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FSG0036100  BOLLORE LOGISTICS SINGAPORE PTE LTD",
            "製造廠廠址": "101 ALPS AVENUE #03-01 SINGAPORE 498793",
            "製造廠公司地址": "",
            "製造廠國別": "SINGAPORE",
            "製程": "貼標廠"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1008200600",
            "成分名稱": "Pomalidomide",
            "含量描述": "Pomalidomide (CC-4047)",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "14 x 6 (+\/-1) mm",
        "特殊劑型": "",
        "顏色": "深藍色\/黃色",
        "特殊氣味": "",
        "刻痕": "無",
        "形狀": "長圓柱形",
        "標記一": "POML",
        "標記二": "1mg"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "POM 1mg-111-01-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026842&Seq=003&Type=10"
        },
        {
            "title": "鉑美特膠囊1毫克_產品照片_1607-105-07-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026842&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Pomalyst TW PI CCDS 12+PPP Ch 20220518-111-07-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026842&Seq=006&Type=9"
        },
        {
            "title": "Pomalyst 1mg_Carton-107-03-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026842&Seq=004&Type=8"
        },
        {
            "title": "鉑美特膠囊1毫克_中文標籤_1607-105-07-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026842&Seq=003&Type=8"
        }
    ]
}